Cox-2 Inhibitors Current Events | Cox-2 Inhibitors News | 7
|
| Page
7 of
20 |
396 Results |
|
|
|
Sort By:
Page Views | Date |
Genetic mutation linked to West Nile virus infection
A genetic mutation that protects against HIV increases the risk of developing clinical West Nile Virus infection. view more (2006-01-09)
Human ageing gene found in flies
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found a fast and effective way to investigate important aspects of human ageing. view more (2008-05-12)
Some hypertension drugs may help reduce dementia risk
Some high blood pressure medicines may help protect older adults from declines in memory and other cognitive function, according to new research from Wake Forest University School of Medicine. view more (2007-05-07)
New hope for advances in treating malaria
Researchers at the University of Leeds have developed chemicals which kill the most deadly malaria-causing parasite, Plasmodium falciparum -- including those resistant to existing drugs. view more (2009-04-22)
Constructing unique analytical instrument for world famous oceanographic institute
Cox Analytical Systems AB, a spin-off company from Chalmers Institute of Technology in Göteborg, Sweden, has just signed a contract with Southampton Oceanography Centre in England to construct an instrument for microradiographic and microchemical analysis of sediment cores. This means that a truly unique instrument will be constructed to make... view more... (2002-09-02)
Study shows PDE5 inhibitor more effective when used on demand in erectile dysfunction
European Urology, the official journal of the European Association of Urology will be featuring the article 'Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy' by F. Montorsi et al.in the October issue, showing for the first time that vardenafil, a PDE5... view more... (2008-08-27)
Nonsteroidal anti-inflammatory drugs use associated with higher gastrointestinal complications
Nonsteroidal anti-inflammatory drugs (NSAIDs) provide a broad range of benefits for patients who require their use, but health care providers need to carefully consider the associated risks before prescribing these drugs for their patients, according to a multi-disciplinary panel of experts convened by the AGA Institute. view more (2006-09-21)
To avoid stomach upset in arthritis patients, drug combination more effective
UCLA/VA researchers found that for arthritis patients, taking a combination of two drugs may be most effective in protecting against stomach upset called dyspepsia, which is a side effect of common pain medications. view more (2006-05-02)
Treatment-induced growth factor causes cancer progression
In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment. view more (2007-04-06)
Embryonic heart exhibits impressive regenerative capacity
A new study demonstrates that the embryonic mouse heart has an astounding capacity to regenerate, a phenomenon previously observed only in non-mammalian species. view more (2008-10-14)
Class of medications may offer alternative option for treating type 2 diabetes
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic... view more... (2007-07-11)
The Hsp90-Antifungal Combo, please: Compromising fungi in the immunocompromised
Even the most drug-resistant fungi can be eradicated in multiple in vitro and in vivo models using a lethal combination of an antifungal agent and inhibition of the heat shock protein Hsp90, according to a new study by Whitehead Institute and University of Toronto researchers. view more (2009-02-10)
MIT-led team IDs gene key to Alzheimer's-like reversal
A team led by researchers at MIT's Picower Institute for Learning and Memory has now pinpointed the exact gene responsible for a 2007 breakthrough in which mice with symptoms of Alzheimer's disease regained long-term memories and the ability to learn. view more (2009-05-07)
Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's
People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications. view more (2009-10-02)
Some blood pressure drugs may help protect against dementia, study shows
A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine. view more (2009-07-23)
Virginia Tech engineer investigates enzyme link to neurological disease
Several neurologically based afflictions, such as Huntington's, Parkinson's, and Alzheimer diseases, have been correlated to a higher than normal presence of a specific type of enzymes, called transglutaminases (TGase) in the human body. view more (2005-08-31)
New evidence shows Rituximab halts damage to joints
New data, presented today at the Annual European Congress of Rheumatology show for the first time that a rheumatoid arthritis (RA) treatment, rituximab, is able to significantly inhibit the structural damage to joints caused by RA in patients who have long-standing disease and an inadequate response to one or more TNF (Tumour Necrosis Factor)... view more... (2006-06-23)
Monkey malaria widespread in humans and potentially fatal
A potentially fatal species of malaria is being commonly misdiagnosed as a more benign form of the disease, thereby putting lives at risk. view more (2008-01-16)
Erectile dysfunction treatments do not appear to damage vision over 6 months
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications. view more (2009-04-14)
Researchers determine timing of administration of platelet-inhibiting drugs
Clinicians should carefully weigh the risks and benefits of when to administer platelet glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibitors for patients with acute coronary syndromes undergoing invasive treatment. view more (2007-02-14)
|
|
| Page
7 of
20 |
396 Results |
|
|
|
Sort By:
Page Views | Date |
|
